APA (7th ed.) Citation

Barthel, H., Luthardt, J., Becker, G., Patt, M., Hammerstein, E., Hartwig, K., . . . Sabri, O. (2011). Individualized quantification of brain β-amyloid burden: Results of a proof of mechanism phase 0 florbetaben PET trial in patients with Alzheimer’s disease and healthy controls. European journal of nuclear medicine and molecular imaging, 38(9), 1702-1714. https://doi.org/10.1007/s00259-011-1821-1

Chicago Style (17th ed.) Citation

Barthel, Henryk, et al. "Individualized Quantification of Brain β-amyloid Burden: Results of a Proof of Mechanism Phase 0 Florbetaben PET Trial in Patients with Alzheimer’s Disease and Healthy Controls." European Journal of Nuclear Medicine and Molecular Imaging 38, no. 9 (2011): 1702-1714. https://doi.org/10.1007/s00259-011-1821-1.

MLA (9th ed.) Citation

Barthel, Henryk, et al. "Individualized Quantification of Brain β-amyloid Burden: Results of a Proof of Mechanism Phase 0 Florbetaben PET Trial in Patients with Alzheimer’s Disease and Healthy Controls." European Journal of Nuclear Medicine and Molecular Imaging, vol. 38, no. 9, 2011, pp. 1702-1714, https://doi.org/10.1007/s00259-011-1821-1.